Loading

Journal of Cancer Biology and Research

Tobacco Control and Lung Cancer Prevention in China

Review Article | Open Access

  • 1. Department of Thoarcaic Surgery Xuanwu Hospital, Capital Medical University, China
  • 2. National Office for Cancer Prevention and Control, Cancer Institute/Hospital, China
  • 3. Office of Tobacco Control, Chinese Center for Disease Control and Prevention, China
  • 4. Department of Epidemiology, Chinese Academy of Medical Sciences, China
+ Show More - Show Less
Corresponding Authors
Xiu-Yi Zhi, Department of Surgery, University of Capital Medical Sciences, China
INTRODUCTION

Tobacco epidemic has been one of most important public health issues in China which kills more than 1.2 million deaths per year [1-3]. Lung cancer mortality in China, used to be ranked at sixth in 1970s with the age-adjusted (by world population) mortality of 7.41 per 100 000, has led the cancer mortalities in the new century. The age-adjusted (by world population) mortality of lung cancer increased incidence were 49.81 per 100 000 and 42.01 per 100 000 for the urban and rural residents of men, respectively, and 23.35 per 100 000 and 19.45 per 100 000 per 100 000 for the urban and rural residents of women in 2009 in the registration areas of China [2,4,5].

Since the 1950s, abundant research data have documented the unequivocal causal relationship between cigarette smoking and lung cancer in developed and developing countries, including China [6-10]. In many cities in China, the regulations of smoking ban in public places have been issued since 1990s. Strict regulations of smoking ban have been well performed in the most public transportation tools across mainland China. However, the epidemic of the tobacco use in Chinese, particularly the cigarette smoking did not have great substantial reduction in the last 40 decades [1,11]. The overall current smoking rates in Chinese adults were reported as 33.7% in 1996, 28.5% in 2002 and 27.9% in 2010 while in Chinese males adults, the rates were reported as 63.0% in 1996, 57.4% in 2002, and 54.0% in 2010. In most public sites and indoor working areas smoking free policies had not been well implemented [11]. The awareness on the health hazards of tobacco use was generally low in the public audience [12,13].

In this paper we present our analysis on the status of the research related to the control of tobacco use and the lung cancer risks in Chinese population.

Lung cancer incidence in Chinese urban and rural population are rising rapidly

On the data from National Cancer Registration, the agespecific incidence rates of lung cancer showed substantially increased over the ages in both the urban and rural areas of China (Table 1). In the males, the rates in the high age groups were always higher than the immediate low groups, from 17% (80-84 years versus 75-79 years) to 225% (40-44 years versus 35-39 years) while in the females, those were from 15% (40-44 years versus 35-39 years) to 211% (45-49 years versus 40-44 years). The rates of lung cancer in the males aged at 45 years or older of the urban residents (except 60-64 years), were 10% to 81% higher compared to the rates of the male rural residents. The male to female ratios were from 1.18 to 2.85 in the urban, and 1.18 to 2.80 in the rural, reflecting the much higher risks for lung cancer in the males than the females regardless the residential classes.

Compared with the two national surveys in last century, the age-specific mortalities of lung cancer in China had been experienced continuous increases in both male and female population, shown in table 2. The mortalities in the ages of 25- 79 years or older in 1990-1992 were higher in all same ages in 1973-1975, increased by 98% (35-39 years) to 362% (75-79 years) in males, and from 97% (35-39 years) to 267% (75-79 years) in females. Continued increases were found again in 2004- 2005 when compared to the rates in 1990-1992, increased by 6% (45-49 years) to 132% (80-84 years) in males of 35-84 years, and 7% (35-39 years) to 115% (75-79 years) in female aged in 35-44 years and 50-54 years or older. Those changes in the age specific rates of lung cancer could not be well explained by the contribution from aging alone. Environmental exposure must play important roles in the development and increase of lung cancer mortalities in Chinese population, particularly from the long term and highly epidemic exposures.

Changes in histological subtypes of lung cancer in Chinese

In a recent report, changes of histological subtypes of lung cancer in Chinese males 2000 to 2012, increased Adenocarcinoma (ADC) and decreased Squamous Cell Carcinoma (SCC), had been observed in the cases from different residential areas, including Beijing, Hebei, Neimengu, Shandong, Heilongjiang, Shanxi, Henan, Liaoning, and Jilin in China , shown as figure 1 [14]. While the cases with SCC were decreased from 39.11% to 32.23%, the cases with ADC were increased from 21.96% to 43.36% from 2000- 2002 to 2009-2012. These histological changes of lung cancer in Chinese males were more likely the following the western countries where the changes of cigarette design, as the filtered cigarette or the low-tar cigarettes were more popular among the smokers [7-10]. Changing the designs of the tobacco products did not reduce the risks of lung cancer in western population and need to be confirmed in the Chinese.

Exposure to passive smoking was consistently critical

Passive smoke contains hundreds of kinds of ingredients Harmful to human body, of which at least 69 species of carcinogens. Passive smoke harm to the health of people is very serious, temporary contact will cause harm to the body. Indoor comprehensive smoking free is the most effective method from second-hand smoke. According to news reports, February 20, 2014-25 PM2.5 concentrations, Beijing continues to be up to 583 micrograms per cubic meter, pollution is very serious, caused the public great attention and concern. Studies show that one cigarette can make indoor PM2.5 concentrations of up to 800 micrograms per cubic meter; three cigarettes more make indoor PM2.5 concentrations reach 1700 microgram/cubic meter. The vast majority of secondhand smoke generated particles will bePM2.5, including a large number of polycyclic aromatic hydrocarbon compound Content, arsenic and benzene and high carcinogenic nitrosamines. When Smoking, indoor PM2.5 stems mainly from second-hand smoke. In 2010 global Grass investigation, aged 15 and over 15 non-smokers, 72.4% are suffering from secondhand smoke exposure in China. According to this estimates, China has 560 million adult non-smokers in secondhand smoke exposure, while there are 180 million adolescents as well. Public places are worst for secondhand smoke exposure. In restaurants the exposure rate is as high as 89%; 67% in the family; 58% in the government building; about 35% in schools, hospitals, transportation. In addition, hotels, bars, workplace secondhand smoke exposure is also very worrying. National smoke-free environment legislation should not be delayed.

In 2010, the prevalence of exposure to Second Hand Smoking (SHS) was particularly high among Chinese nonsmoking adults, 72.4% reported exposed to SHS in the past 30 days and 38.0% being exposed almost every day [5]. Exposure to SHS was especially high among leaders of organizations (85.8%), and business and service employees (83.1%). Then, in China, there could be more than 500 millions nonsmokers had exposed to SHS at least once a week. No significant difference had been found in the prevalence of exposure to SHS between men (74.1%) and women (71.6%), nor between the residents in rural (74.2%) and urban (70.5%).

Table 1: Age-specific incidence of lung cancer in Chinese population, 2009.

year                  All areas              Urban areas           Rural areas
               Male Female             Male Female         Male Female
25-         1.24  
30- 1.73 1.12 1.44 1.18 2.26 1.03
35- 3.88 3.26 3.92 3.33 3.80 3.21
40- 12.60 3.79 12.92 6.21 13.46 7.97
45- 24.52 11.8 25.42 12.38 22.45 10.50
50- 54.39 22.67 55.42 21.46 50.79 25.77
55- 91.32 35.26 93.52 32.86 86.22 41.18
60- 142.14 57.24 141.23 55.99 144.05 60.05
65- 231.06 87.55 246.42 94.95 201.72 72.17
70- 370.06 174.74 386.39 191.37 331.97 133.64
75- 530.35 231.68 563.67 257.99 442.23 164.42
80- 619.54 281.74 677.90 315.50 464.62 199.48
80+ 602.55 243.00 684.16 279.89 377.22 150.05

(Data: National Cancer Center [1])

Table 2: The age-specific mortalities of lung cancer in China from 1973 to 2005.

year                 1973-1975              1990-1992           2004-2005
               Male Female             Male Female         Male Female
25- 0.60 0.46 1.43 1.10 1.16 0.63
30- 1.28 0.93 2.91 1.84 2.62 1.63
35- 2.96 1.90 5.87 3.74 6.59 3.99
40- 5.98 3.42 12.14 6.55 13.33 7.75
45- 11.43 5.96 22.44 11.61 23.80 10.49
50- 18.99 9.09 40.57 19.23 54.82 21.18
55- 28.66 1221 71.92 28.77 93.55 36.01
60- 38.34 1571 122.82 43.32 137.53 55.51
65- 46.68 19.55 145.33 53.49 199.88 77.84
70- 49.04 21.21 186.50 69.65 300.11 122.29
75- 40.15 19.07 185.54 69.98 370.37 150.32
80- 29.08 16.17 172.63 84.65 400.06 168.38
80+     170.96 83.53 340.19 205.92

(Data source: Chen WQ [4])

Table 3: Scores of awareness of tobacco control among smoking and non-smoking staff.

Awareness questions Average score1
(±standard deviation)
Smokers Non-smokers
Comparison of smokers 
with non-smokers
                    Z P
Smoking behavior        
Less smoking and little harm 0.6±0.3 0.8±0.3 4.69 <0.001
Lower tar means less harmful 0.5±0.3 0.8±0.3 4.11 <0.001
Passive smoking is less harmful 0.8±0.3 0.9±0.2 3.57 0.004
Patients with a long time smoking should smoking less rather quit 0.5±0.3 0.5±0.3 1.04 0.297
As a chronic disease, smoking addiction needs medical treatment 0.6±0.3 0.7±0.3 1.71 0.087
Smokers with quit will could quit succeed 0.5±0.3 0.4±0.3 -1.24 0.216
Physicians should set the example to refuse smoking 0.8±0.3 0.9±0.2 2.71 0.007
Smoking should be completely forbid in every hospitals 0.8±0.2 0.9±0.2 2.25 0.025
Smoking could be fine when staffs have no direct contacts with patients 0.7±0.3 0.9±0.2 4.87 <0.001
Health risks of active smoking        
Prostatitis 0.6±0.3 0.7±0.2 2.19 0.028
Hypertension 0.7±0.3 0.8±0.2 2.29 0.022
Osteoarthritis 0.5±0.2 0.6±0.2 2.38 0.017
Lung cancer 0.8±0.2 0.9±0.2 3.46 0.005
Ischemic heart disease 0.6±0.3 0.7±0.4 0.66 0.508
Sexual dysfunction 0.7±0.3 0.8±0.2 2.13 0.033
Tuberculosis 0.7±0.3 0.8±0.3 0.86 0.390
Type II diabetes 0.5±0.2 0.6±0.2 1.83 0.067
Acute gingival necrosis or ulceration 0.7±0.3 0.8±0.2 1.55 0.122
Emphysema 0.8±0.3 0.9±0.2 2.41 0.016
Health risks of passive smoking        
Leukemia 0.5±0.2 0.7±0.3 2.81 0.005
Lung cancer 0.8±0.3 0.9±0.1 3.05 0.002
Ischemic heart disease 0.6±0.3 0.7±0.3 1.79 0.073
Bronchitis 0.8±0.3 0.8±0.2 1.57 0.117
Stroke 0.6±0.3 0.7±0.2 2.81 0.005
bronchiolitis 0.7±0.3 0.8±0.2 1.61 0.107
Asthma 0.8±0.3 0.8±0.2 1.26 0.209

1 The ideal value is 1.0.

AWARENESS ON HEALTH HAZARDS OF TOBACCO USE WAS GENERALLY LOW

We conducted a survey on the awareness of health hazards of tobacco use in the staff in a cancer institution at Beijing in 2010. Analysis on the data from 159 responds showed that the scores of the tobacco knowledge were lower in the smokers than the nonsmokers for a number of questions, including concerning the quantities of smoking, low-tar cigarettes, passive smoking, and awareness the health consequences of tobacco use, such as prostatitis, hypertension, Osteoarthritis, shown in Table 3. Of 26 questions interviewed, only 7 had scores higher than 0.9 (full score is 1.0) in nonsmokers and none in smokers, suggested that the health hazards of tobacco use should be highlight and put as an important priorities of the health education programs for both the public and the health providers in China. Actions against the tobacco use in China should be widely strengthened Since the Framework Convention on Tobacco Control (FCTC) was ratified in China, there has been a strong push for national legislation, and progress is being made at both the municipal and national levels. But there are some limitations: including banning smoking in limited places; the executive bodies of the law are not clear; and most laws are difficult to implement, the executive bodies of the law are not clear; no any punishment and most laws are difficult to implement. Since 2008, several cities have enacted smoke-free legislation and more are actively drafting such legislation. Currently, none of the mainland cities are in compliance with Article 8, but there is growing confidence in the public acceptance of this legislation and the feasibility of enforcement. At the national level, in 1991, the Ministry of Health issued the Implementation Guidelines of the Regulation on Public Places Health Management and Smoking in which implementation guidelines banned smoking in 13 types of public places. Based on these guidelines, industry specific regulations for smoke free public places have been developed and implemented since 1997. The most important national achievement is that in 2009 the Ministry of Health joined three other national health authorities to issue a Decision on smoke-free health facilities. The Minister of Education and the Ministry of Health jointly issued a similar Decision on smoke-free schools in 2010. Though not legally binding, these decisions and guidelines are being implemented and enforced with rigour. The most impressive measures of smoke free legislation and policies include: the Ministry of Health taking the lead and setting an example by building a smoke-free Ministry of Health; continued support of the smoke-free facilities efforts in various regions in partnership with the Central Government Subsidy to Regional Tobacco Control Projects; expert supervision of the building of a regional smoke-free health care system; implementation of China tobacco control mass media communication campaigns; third-party professional survey conducting inquiries into the nationwide building of smoke-free health care institutions. Although efforts were made, major breakthroughs still needed in the development and implementation of policies, regulations and laws on banning smoking in all indoor public places in China.

Citation

: Zhi XY, Zou XN, Hu M, Jiang Y, Qiao YL (2014) Tobacco Control and Lung Cancer Prevention in China. J Cancer Biol Res 2(1): 1044.

Absract

In recent decades the age-specific mortalities of lung cancer in China have been  increased to 9 times in men and women and it become one of the most important  public health issues. The high prevalence of smoking in men and more than 70%  of nonsmokers, both men and women, could be the biggest contributable factor for  those consequences. While the abundant evidence on the health risks of exposure to  smoking were available in both international and domestic studies the awareness on  the health hazards from tobacco use were quit low in Chinese peoples, even in the  health providers. Changes in the contents and the process of the tobacco products in  Chinese tobacco product markets were accompanied by increased numbers of the  lung cancer cases, increased adenocarcinoma and decreased squamous cell carcinoma  of the lung, rather than reducing the overall lung cancer cases. Those suggested that  comprehensive smoking-free policy should be implemented in all public places and the  process of smoking-free legislation should put forward to create the legal environment  and provide effective protection for reducing the incidence of lung cancer. Popularized  health education should be also enhanced to raise the public awareness on smoking  hazards. 

REFERENCES

1. National Cancer Center, Disease Prevention and Control Bureau of Ministry of Health (2012). Chinese Cancer Registry Annual Report. Military Medical Science Press, Beijing. 2012; 28-39, 72-75.

2. Liu BQ, Peto R, Chen ZM, Boreham J, Wu YP, Li JY, et al. Emerging tobacco hazards in China: 1. Retrospective proportional mortality study of one million deaths. BMJ. 1998; 317: 1411-1422.

3. The Ministry of Health of the People’s Republic of China (edit). Report on Third national retrospective sampling death survey. Beijing: Peking Union Medical College Press. 2008; 10-29.

4. Chen WQ. The lung cancer. In The National Office for Cancer Prevention and Control, National Central Cancer Registry, The Disease Prevention and Control Bureau of Ministry of Health (edit). China Death Report  Third National Retrospective Sampling Survey on the Mortality. Beijing: Peoples’ Health Press. 2010; 24-36.

5. Chinese Center for Disease Control and Prevention, the Center for Chronic Disease Control of Chinese Center for Disease Control and Prevention. Report on chronic disease risk factor surveillance in China 2010. Military Medical Science Press, Beijing. 2012. 8-36.

6. Wang CP, Ma SJ, Xu XF, Wang JF, Mei CZ, Yang GH. The prevalence of household second-hand smoke exposure and its correlated factors in six counties of China. Tob Control. 2009; 18: 121-126.

7. Sansone G, Fong GT, Hall PA, Guignard R, Beck F, Mons U, et al. Time perspective as a predictor of smoking status: findings from the International Tobacco Control (ITC) Surveys in Scotland, France, Germany, China, and Malaysia. BMC Public Health. 2013; 13: 346.

8. Thun MJ, Day-Lally CA, Calle EE, Flanders WD, Heath CW Jr. Excess mortality among cigarette smokers: changes in a 20-year interval. Am J Public Health. 1995; 85: 1223-1230.

9. Giovino GA, Mirza SA, Samet JM, Gupta PC, Jarvis MJ, Bhala N, et al. Tobacco use in 3 billion individuals from 16 countries: an analysis of nationally representative cross-sectional household surveys. Lancet. 2012; 380: 668-679.

10. Khuder SA, Dayal HH, Mutgi AB, Willey JC, Dayal G. Effect of cigarette smoking on major histological types of lung cancer in men. Lung Cancer. 1998; 22: 15-21.

11. International Agency for Research on Cancer. Tobacco smoke and involuntary smoking. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, IARC Scientific Publications. 2004; 83: 171-172.

12. Jiang Y, Ong MK, Tong EK, Yang Y, Nan Y, Gan Q, et al. Chinese physicians and their smoking knowledge, attitudes, and practices. Am J Prev Med. 2007; 33: 15-22.

13. Guo YM, Zhang FQ, Yan HY, Wang HJ. Investigation of Medical staff’s smoking status, knowledge, attitude and behavior related to tobacco control. Chinese J of Epidemiology. 2009; 30: 289.

14. Zou XN, Lin DM, Wan X, Chao A, Feng QF, Dai Z, et al. Histological subtypes of lung cancer in Chinese males from 2000 to 2012. Biomed Environ Sci. 2014; 27: 3-9

Received : 02 Apr 2014
Accepted : 24 Apr 2014
Published : 30 Apr 2014
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X